Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair

Anna Krasnodembskaya (Belfast, United Kingdom)

Source: ERS Lung Science Conference 2020
Number: 30

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anna Krasnodembskaya (Belfast, United Kingdom). Metabolic reprogramming by mesenchymal stem cells as a strategy for lung repair. ERS Lung Science Conference 2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021


Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Bone marrow derived mesenchymal stem cells accelerate alveolar epithelial repair in vitro
Source: Annual Congress 2007 - Cell-based tissue modulation: the good and the ugly?
Year: 2007


Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021


Mesenchymal cells, immune cells and the lung stem cell niche
Source: Eur Respir Monogr 2021; 91: 134-143
Year: 2021


Oral presentation: Mesenchymal induction of lung endoderm progenitor cells from embryonic stem cells
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009



Lung stem cells and the role of the stem cell niche
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009



Efficient gene transduction of adipose tissue-derived mesenchymal stem cells (MSCs) for asthma research
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011


iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021



Mesenchymal stem cells in aging and IPF
Source: ERS Research Seminar 2017 – Integrating systems biology approach in idiopathic pulmonary fibrosis research
Year: 2016


Use of alveolar epithelial cells derived from induced pluripotent stem cell to study alveolar wound repair in vitro
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018

Alveolar epithelial stem cells in homeostasis and repair
Source: Eur Respir Monogr 2021; 91: 122-133
Year: 2021


Characterisation and hepatocyte-like differentiation of mesenchymal stem cells derived from adipose tissue of immunodeficient mice
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


Pulmonary transplantation of human induced pluripotent stem cell-derived macrophages
Source: International Congress 2019 – Airway regenerative medicine: from bench to bedside
Year: 2019


Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018